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supplanted by science, he argued, “so long as human nature is 
what it is, culture would continue to provide mankind with its 
fulcrum of moral understanding”. I would suggest that there is 
still a role for science and art in modern medicine and I wish 
to show that they should be interlinked in the training for and 
practice of medicine.
BEAUTY
So what is beauty? First let me perhaps surprise you by stating 
that beauty can be defined numerically:- 1.6180339887. That 
is beauty - that is the golden ratio (fig 1). It was described by 
the Pythagorean mathematicians, as they kept seeing this ratio 
in things regarded as beautiful, and it was first written down 
by Euclid, and can be expressed either as a linear relationship 
or as a shape, in either case the ratio is (a+b) is to a as a is to 
b and is behind the pattern of many shapes we find pleasing, 
be it architecture, form, people - all tend to this ratio when 
regarded as beautiful, and with that ratio we also expect to find 
balance and symmetry. The Parthenon has these ratios, and 
balance. People also and if we look at those regarded today 
as beautiful, then again the ratio applies, as does symmetry, 
both to the face and body. The head forms a golden rectangle 
and the mouth and nose are placed at golden sections of the 
distance between the eyes and the chin, and there are many 
others present and when we look at the human body then the 
INTRODUCTION
Let me start with Confucius who said “everything has its 
beauty but not everyone sees it”. Beauty is... We all remember 
sayings such as beauty is skin deep, is only skin deep, is not 
only skin deep, is in the eye of the beholder, comes from 
within and so forth. The American writer Jean Kerr said 
“I’m tired of all this nonsense about beauty being only skin 
deep. That’s deep enough. What do you want - an adorable 
pancreas?” And for those of you who believe in the new 
saying that beauty is in a jab and have come to hear about 
Botox, peels and fillers, they will not get a mention, so do 
leave now if you wish. But before you go, let me draw your 
attention  to  a  poem  of  Thomas  Campion  a  Renaissance 
English poet, of whom it was said “he had the generous 
illusions of youth; devoted to the studies of poetry, music, 
and medicine, clothed with that finer tact and sympathy which 
comes to a good physician”, surely still applicable to today’s 
students, but in his poem he said: 
“Beauty is but a painted hell;    
shee wounds them that admire it,    
shee kils them that desire it.     
Give her pride but fuell,     
no fire is more cruell.”
But beauty is not just a visual experience; it is a characteristic 
that provides a perceptual experience to the eye, the ear, the 
intellect, the aesthetic faculty, or the moral sense. It is the 
qualities that give pleasure, meaning or satisfaction to the 
senses, but in this talk I wish to concentrate on the eye, the 
intellect and the moral sense. 
It was the late CP Snow, a true polymath, who gave the Rede 
lecture in 1959 and subsequently wrote a book, both under 
the title The Two Cultures, in which he bemoaned the split 
that had taken place between the scientists and the literary 
intellectuals. In education, when I was at school and to a 
large degree it remains, even today, there is a division as to 
whether one follows a scientific or an arts direction, to the 
detriment of the other.  His theory was boosted when the 
critic FR Leavis published his attack on the Two Cultures. 
He wrote of Snow’s “complete ignorance of history, literature 
and the history of civilization… his incapacity as a novelist 
is … total… not only is he not a genius he is intellectually as 
undistinguished as it is possible to be.” For those of you who 
have come expecting a little gentle admonition, I am afraid 
you are going to be either relieved or disappointed; as there is 
no way that I could match that. But it is one of history’s ironies 
that nearly eighty years earlier, Matthew Arnold in giving the 
same lecture had made the opposite point. Written in response 
to an argument that literature should and inevitably would be 
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ratio in the average human body of the distance between the 
navel and the foot to the height and the ratio of the distance 
from the top of the head to the fingers to the height is the 
golden ratio, and again there are many others present. And 
we find these proportions in art for instance in the Sutherland 
tapestry of Christ in Glory in Coventry cathedral. 
And  not  to  leave  out  other  specialities,  for  instance  my 
respiratory colleagues - the divisions of the bronchi follow 
the rule and for our dental colleagues, the arrangement of 
the central incisors also. And the result of being perceived 
as beautiful is the person is thought more intelligent, more 
trustworthy, more likely to be employed and at better salary. 
These perceptions are important to us all but perhaps more so 
is the reverse perception of people with skin disease and the 
perception of those around them of the nature of skin disease. 
We are aware of the entries in the Bible, with its descriptions 
of what it called leprosy and the need to make others aware 
that you are unclean, you are dirty, and you are contagious. It 
has produced the leper complex for both the sufferer and the 
observer, still present today.
The descriptions given in the Bible covered many diseases 
other than leprosy, many of which were not contagious, such 
as psoriasis. However they were not too far off the mark with 
their anxiety and worry over so-called leprosy of clothes and 
buildings. My late colleague Dr Martin Beare showed that 
the fungus that causes cattle ringworm can survive in a sealed 
glass test tube for over a year and be successfully recultured. 
So also the fungus can survive on buildings, fencing and 
hedging, and continue to cause skin problems not only to 
host animals with a financial and user implication if the hide 
is seen as imperfect, but also to humans.
In all our dealings with patients with rashes there is constantly 
the  “leper  complex”,  and  overlaid  on  that  is  the  social 
importance of the skin. Look at the glossy magazines and the 
pages given to appearance. Appearance is everything. It is the 
first thing seen by others in social situations. The skin is one 
of the most important components of an individual’s physical 
appearance. The skin on the face is under almost constant 
scrutiny in our daily interactions, though often unconsciously. 
If a person’s form or colour is damaged then beauty maybe 
lost, and in modern society, individuals with an atypical facial 
appearance are often prejudiced against, and may experience 
severe social handicap, and the same applies to hand rashes.
Let  me  take  psoriasis  as  an  example  of  a  chronic  non-
contagious  dermatological  disorder  associated  with 
cosmetically  disfiguring  skin  lesions,  often  with  severe 
social impact on the patient. The majority of patients feel 
they are stared at because of their psoriasis and regarded as 
contagious. They may experience outright rejection; asked to 
leave places such as a swimming pool, a gym or hairdresser. 
And because they anticipate rejection, they avoid these public 
places or interpersonal situations and thus reduce the quality 
of their life and social opportunities. It is always salutary to 
hear patients talking about their real problems, when they 
are talking casually together, then issues such as scaling in 
patients with psoriasis come to the forefront. The person who 
takes a vacuum cleaner on holiday, or the civil servant with 
a dustpan and brush in his briefcase to brush up around his 
chair before leaving work.
The other skin condition particularly associated with social 
stigma is acne to which many of today’s intended audience can 
relate, and which may lead to depression. The severity of acne 
can determine participation or rather lack of it in daily social 
activities, and adds to all the other pressures of adolescence. 
Individuals growing up in western society learn to believe 
that attributes such as clear skin, strong nails and clean hair 
are what are needed if one is to achieve that elusive quality 
of beauty. Therefore, if one lacks these features, because of 
a skin disorder then one is no longer seen as attractive or 
beautiful. 
So from that how can I discuss skin disease as beautiful? So 
where is there beauty in skin disease. Might I suggest that it 
is there in colour, in form, and in pattern? I am not aiming 
to make you dermatologists, but let me suggest with a few 
slides that there is beauty in the appreciation as well as the 
physical appearance of some conditions. For instance colour. 
Like paint colour cards, a spectrum from pink to many shades 
of red, and yet all from the same condition, orangeybrown, or 
black. Or shape round with a ripple effect in tinea corporis, 
or with a target like appearance in erythema multiforme, or 
a non-anatomical patterned shape in dermatitis artefacta, a 
square, psoriasis in a donor graft site, or typical pattern of 
contact dermatitis from Elastoplast, or serpiginous from a 
larva of a worm. Do be wary of sitting on the sand on your 
next exotic holiday. I recently had a young patient who wasn’t. 
And what about a blister? The intellectual reward of making a 
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diagnosis purely from its appearance (fig 2). The thickness of 
the roof, the contents, the background, and also the mystery, 
why is there no surrounding inflammation? And what about 
the beauty of histology, staining for immunoglobulins in a 
blister, and routine histology surely beauty if only in colour, 
and metachromatic staining with purple of the mast cells 
using a blue dye, part of the fun of my intercalated degree. 
Enjoy the general picture of pathology, and then you will start 
recognising changes. Stay friends with your pathologist, who 
is still the last port of call for a tissue diagnosis, and as it 
seems a prerequisite of these lectures that Osler should have 
at least one quotation, then I would agree with his “As is your 
pathology, so is your practice”. Clinical and pathological is the 
complete package. And while we are in the laboratory, what 
about fungal cultures (fig 3)? Surely there is a beauty in these? 
And what about the wee beasties; the flea and the adult head 
louse. Surely more than just their mothers love them. But as 
Confucius said “.. not everyone sees it”. So there is beauty to 
be seen, the visual.
Secondly beauty and the intellect, beauty as knowledge. The 
more we know about a disease process the better we can 
manage it. For those considering research; advice I heard 
from Farrington Daniels junior, a photodermatologist and 
US government advisor in the 70’s, that he gave his residents, 
was to read the standard textbook, find the most dogmatic 
statement and then look. It was often wrong. It has been 
written; “every fact of science was once damned.  Every 
discovery was a nervous shock to some orthodoxy. We would 
own no more, know no more, and be no more if it were not 
for the rebellious, the recalcitrant, and the intransigent.” Or 
Oscar Wilde put it more succinctly, “disobedience was man’s 
original virtue” - my apologies to the chaplains. 
 So how has improved knowledge helped with psoriasis? How 
has it and how should it influence management? As we are 
nowhere near competing with those looking for the Higg’s 
boson at CERN, the only comments I wish to make at the 
subcellular level is that the accepted wisdom that psoriasis 
was a condition of rapidly increased cell turnover of a few 
basal epidermal cells has changed to a normal rate turnover 
of increased numbers of cells, support for looking at accepted 
wisdom, and secondly that increased knowledge regarding 
inflammatory  mediators,  present  in  large  quantities,  has 
led to the introduction of a whole new class of therapeutic 
agents,  the  biologics. At  the  genetic  level,  although  nine 
chromosomal loci have so far been described, even a major 
gene only determines 35-50% of the heritability, and that only 
in certain phenotypes.
We  are  however  advancing  enough  to  have  a  significant 
effect  on  therapy,  where  the  emphasis  has  changed  from 
one of reducing epidermal cell turnover, to dealing with the 
abnormalities of the inflammatory process. However for many 
years treatment has been anything but beautiful - creams and 
ointments. Imagine covering all your skin in an application, 
even just a moisturiser, at least twice per day. Then think 
if you had to apply a tar based product, the colour and the 
aroma, or one that stains; no wonder compliance was and 
is low. So you can imagine the joy of patients exposed to 
modern light treatment, slightly offset when they realised they 
still had to moisturise, and then the delayed findings of an 
increased risk of skin cancer. Systemic drugs were also much 
appreciated as generally easy to take, but still moisturisers 
were needed and there were side effects, the liver, kidneys, 
immunosuppression and fetal abnormalities.
And  now  the  biological  drugs.  But  of  course  there  is  a 
downside such as re-activation of TB and increased rates 
of infection. When they work it seems miraculous to the 
patient,  as  they  add  a  further  weapon  to  our  therapeutic 
armamentarium, but they do cost, though the NHS Economic 
Evaluation Database has accepted a German paper1 showing 
an  economic  advantage  of  etanercept,  a  biologic,  over 
conventional therapy for certain groups of patients. So for 
each treatment there is a balance of gains and loss.
Therefore can we make topical agents easier to use, retain 
their apparent better safety profile, and at low cost? A major 
direction at present seems to be in the field of nanotechnology. 
A nanometer one billionth of a metre; the ratio of a marble to 
the earth; the length a hair in the beard grows in the time it 
takes to lift a razor to the face. I suspect that if you remember 
nothing else from this lecture you will about beard growth.
As so often it is the cosmetic companies, who are leading the 
research especially with sunscreens, and of course everyone 
who has to apply topical agents wants cosmetically acceptable 
ones. But there seems a long way to go. We do not know how 
many chemicals act when at the nano size. One cannot simply 
transpose the behaviour of large molecules, with which we are 
familiar. I am also very wary of technology in which military 
agencies are interested. If we are concerned by the spread of 
CCTV then think if a nanoparticle could be applied to you, 
without your knowledge, giving a constant readout of where 
and what you were about. As usual the balanced debate is 
being led by the newspapers. For instance, “if your suntan 
lotion can change the sex of fish, what can it do to you?”,   
“The stuff is not only on your skin - it’s in your tap water and 
lunches, too”. “They can penetrate the brain”, but companies 
are saying that the zinc oxide nanoparticles are fixed in the 
lotions, and are inert, while others suggest that none are inert 
at this size. So there is still a way to go.
There remain many holes in our knowledge. We have no 
explanation for distribution - psoriatic plaques are normally 
over the knees and elbows; but then why is guttate psoriasis 
predominantly on the trunk? Again little is known about the 
natural history, predictors of disease severity or remission. 
There are no biomarkers estimating activity. And if cleared 
by treatment, is it really clear? There remain many mysteries.
I am sure we all expect new knowledge at the subcellular level, 
but there is much new knowledge available at the patient and 
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societal level, which is probably more important to the patient, 
and this reflects a theme that is common to many specialities 
who deal with chronic inflammatory disease. Many years 
ago the late Professor Pantridge asked me how and why did 
patients with psoriasis die. I did not have an answer, but in 
my defence they so rarely died under our direct care that we 
had no idea of the causes of death. Now a major advance is 
the increasing realisation of comorbidities, associated with 
chronically increased levels of pro-inflammatory mediators 
as seen in psoriasis2. 
Psoriasis  is  associated  with  metabolic  syndrome  (obesity, 
impaired glucose tolerance, abnormal levels of fat in the 
circulation, arterial hypertension and is twice as common 
in forty to sixty year-old patients with psoriasis as among 
healthy  people.  In  addition  significant  coronary  plaques 
are twice as common in patients with psoriasis compared 
to controls and a thirty year-old patient with moderate to 
severe psoriasis has a threefold increased risk of myocardial 
infarction  with  mortality  due  to  myocardial  infarction  or 
stroke two and a half times higher in patients characterised 
by early or frequent hospitalisation. Psoriasis is not just a skin 
disease or joint disease after all. The other major improvement 
in knowledge is the ability to measure the burden, especially 
psychological, both for patients and for their helpers and 
give them numbers that are robust and reproducible. Better 
than the simple   “ how are you feeling”. The SF36 short 
form, with its 36 questions, is used to compare the impact of 
different diseases. The lower the score the bigger the impact. 
Psoriasis with diabetes and worse than cancer3. There are 
specific survey forms for psoriasis, the PASI - a physician 
determined score based on erythema, or redness, degree of 
scaling, induration and area of skin surface involved, and 
Quality of Life issues such as the dermatology life quality 
index4, a patient determined index, consisting of 10 questions 
related to symptoms and feelings, daily activities, leisure, 
work  and  school,  personal  relationships  and  trouble  with 
psoriasis treatment. Both score from 0 - 30, with lower scores 
corresponding to a better quality of life. Moderate to severe 
disease is with a PASI >10 either alone or with a DLQI >10. 
HOW DO SCORES TRANSLATE TO MANAGEMENT?
In over 1500 patients attending dermatologists5, there was a 
mean PASI of 12.0 with mean disease duration of 17.6 years. 
Over a quarter had been hospitalised; virtually all had had 
topical therapy and two-thirds had UV-phototherapy, but only 
one third systemic therapy. There was a severe sub-group of 
~20% of patients with a PASI > 20, in whom 12 workdays had 
been lost in the previous 12 months per patient. Virtually one 
fifth were unable to work (mean = 133 days), half had been 
hospitalised in the last 5 years, almost 60% had a DLQI > 10 
and yet less than 50% had had systemic therapy. That does 
not seem to read very well.
But  it  is  not  just  the  patient  who  is  affected.  In  another 
study6 looking at the effect on others in the household, there 
were 63 subjects questioned of whom 28 were relatives and 
35 partners. The Patients themselves had a mean DLQI of 
10, and mean PASI 5.2, and 40 aspects of quality of life 
were  identified  in  6  categories.  The  results  showed  that 
70% complained of extra time on housework, laundry and 
vacuuming, 57% of psychological pressures (mainly anxiety 
and worries about the future), 55% of social disruption (such 
as meeting people), 44% of holiday plans (including sport and 
leisure), 37% of daily activities, shopping, work and dealing 
with other members of family, and the same figure for effects 
on personal relationships.
The  subjects’  Quality  of  Life  was  related  to  the  patients 
Quality of Life and not disease severity scores. There certainly 
appears to be room for improvement, but I wonder how figures 
would look in other specialities.
WASHING AND SUNTANS
Having said at the beginning that I was not going to discuss 
Botox etc. I am going to discuss two activities that related to 
beauty have had a singular effect on dermatology services in 
recent times. 
The  first  of  these  is  washing  and  the  associated  beauty/
cosmetic business and the use of water. In 1961 water used 
per head for bathing was 11 l/day, rising to 51 litres in 1997. 
For 2008 around 80 litres per day is necessary. This is out of a 
total daily usage in England of 145-150 litres per person, per 
day.  UK sales of bubble baths have risen from £76 million 
in 1981 to £173 million in 2001. Total UK sales in 2006 
were £4 billion for personal wash products. With all the skin 
washing we are seeing an increase in the amount of dry skin 
and eczema, especially in the vulnerable skin of the young 
and the old, who then need to apply moisturisers. There are so 
many complaints of reactions to topicals that manufacturers 
seem to list more of what is not present than is. 
The second major activity, that was pre-eminent in the last 
century as an aid to beauty, was that of acquiring a suntan. 
People went on holiday to get a tan, and if you came back pale 
it had been a failure; and what has been the result? Let us look 
at the pin-up girl to a certain generation - Brigitte Bardot. If 
one compares pictures of her in her prime in the late 1960’s 
to those, even in the early 1990’s, one can see enormous 
changes in terms of wrinkling and elasticity, showing the 
effects principally of the sun. If symmetry and balance are 
beauty look how easy it is to destabilise just by attaining a tan. 
If aging changes are not enough to frighten you, what about 
the development of skin cancer? There is a problem when we 
come to look at the figures. Nationally, if figures are collected 
at  all  for  non-melanoma  skin  cancer,  then  only  the  first 
episode is recorded and the Northern Ireland Cancer Registry 
has followed this practice. A registry audit suggested that 50% 
more skin cancers are removed than patients registered. We do 
have patients who have had up to 50 and more primary basal 
cell carcinomas removed. Using the 2007 pathology figures 
for the Belfast trust, which included some material from the 
Ulster hospital, then of 52,000 biopsies reported that year 
approximately a third of all, just under 14,000, were for skin 
lesions of which 2097 were for basal cell carcinoma, and 489 
for squamous cell carcinoma.
Unless you have been living totally in your own world, then 
you  must  be  aware  of  the  issues  surrounding  malignant 
melanoma; the increases that have occurred in the latter part 
of last century. In a recent paper7, between 1984 and 2005 
in the province there has been a 288% overall increase, with 
males at 340% and females 260% but again this does not 
reflect the true work implications. Virtually every MM has two 
surgical procedures the first being to excise the lesion, which © The Ulster Medical Society, 2009.
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allows histological staging, and a wider second excision. In 
addition the best centres in the UK would suggest that around 
20-25 moles are removed for every malignant melanoma, and 
there are no figures available for the number of pigmented 
lesions that are referred, that do not require biopsy or surgery. 
In 2007 there were 291 malignant melanomas reported in the 
Belfast trust (Dr Maureen Walsh, personal communication) 
with a further 1797 benign naevi, which at a figure of 8 to 
1 benign to malignant gives us a much better figure than 
elsewhere, but raises a question are we not removing enough? 
And  that  does  not  include  other  pigmented  lesions.  Our 
figures suggest that we see three patients for every one who 
has a procedure. For the trust that means about 5,400 cases a 
year have to be red flagged, that is seen within two weeks of 
referral for query malignant melanoma, or changing mole, 
and does not include other red flag items. If all this work is 
the result of recent efforts to achieve a desired appearance 
what does the future hold for my successors from some of the 
present techniques that the public willingly undergoes seeking 
beauty, and delaying aging? 
Having  mentioned  the  beauty  that  lies  in  symmetry  and 
balance, we can see this even when we look at skin cancer. A 
basal cell carcinoma relatively banal, in this type is balanced 
and symmetrical.  Benign moles again are symmetrical and 
balanced, but when malignant, asymmetrical and unbalanced. 
There is no beauty. This is the price of achieving beauty.  
It has had a distorting effect on our work balance of skin 
cancers and pre-cancers vs. rashes, new and review. A recent 
Edinburgh study8 reported that 46% of their new referrals 
were for tumours, benign and malignant and 24% for psoriasis 
and eczema, but only 20% of reviews were for cancer with 
40% for the big three rashes, eczema, psoriasis and acne. 
Their new referral rate has risen by 67% between 1980 and 
2005, from 12.6 per 1000 population to 21. And interestingly 
over the same period internal referrals had almost quadrupled 
to 11% of total in 2005.
Andrew Finlay9, in the 2000 Dowling Oration, (the big annual 
set piece of British Dermatology), made a particular plea 
for  medical  dermatology,  which  he  saw  being  threatened 
politically  by  the  emphasis  on  seeing  skin  “lumps  and 
bumps”. He asked the question “Are we meeting patient’s 
needs?” I have already largely answered that question. I have 
discussed the shortfall in medical management and patient 
desires for clean and easy to use treatments. Skin tumours are 
usually simply cured by surgical techniques, but this is not 
the same for the chronic inflammatory skin conditions. We 
do not have cures, treatments are messy, compliance is poor, 
36% of parents of children with atopic eczema admit to non-
compliance. Knowledge and education outside secondary care 
is inadequate. Research has shown that the disability suffered 
by those seen in primary care and not referred on was just 
as marked as those sent to secondary care, and in a Welsh 
study10 looking at Quality of Life scores after attendance 
at a dermatology clinic, the greatest benefit was perceived 
by those with psoriasis, eczema and acne ahead of those 
with cancer. There is a great untapped need. This suggests 
that patients with severe inflammatory skin disease deserve 
priority in the organisation of skin clinics, which seems to 
have been lost in the drive to deal with skin malignancies.
I was therefore delighted to read the consultation document 
from the board of the Belfast Trust entitled ‘New Directions’, 
with its particular emphasis on patient choice. Ours will be 
very expectant, and also the need for centres of excellence 
to provide the knowledge, skills and critical mass to provide 
these desired treatments. A chronic inflammation diseases 
emporium to match the cancer centre. One can but dream. 
This lecture by tradition has been directed at the new clinical 
medical students, so if mathematicians, engineers, architects 
strive for beauty as the right solution to a problem, then even 
more that should be your aspiration as you draw a picture of 
medical care that you give and it does not matter what the 
condition is, nor what speciality you are in. However one of 
your biggest challenges will be to draw the same standard of 
picture for everyone you deal with. You will be challenged 
by the so-called heart sink patient, the alcoholic, the drug 
addict, and the prisoner. It is a real challenge to provide the 
same service to a prisoner who has killed, as it is to the widow. 
A recent anonymous personal view column in the BMJ said 
“we all meet patients who make our hearts sink. We will all 
meet patients who challenge our personal values and beliefs. 
We will all meet patients who will fill us with a sense of 
disapproval”. How will you treat them? At the same time do 
not be seduced to provide a better service for those who might 
be perceived as important. Do not cut corners “being nice” 
when caring for colleagues. 
But if you are to be enabled to produce the best picture of care 
there are two major parts of the picture missing from what I 
have already discussed, and to an extent outside your control 
and that is your medical education, which has been such an 
important tradition of this hospital, from its inception, and 
secondly the politico- managerial influences on health care. 
When I left the academic staff of this medical school we had 
amongst the worst staff - student ratios of the old medical 
schools in the UK. Since then the student numbers have risen 
from 864 in 2000 to 1160 in 2007, whilst there has been 
minimal change in the numbers of clinical academic teaching 
staff. The result is large numbers of students going through 
many clinical attachments, each in a very short time, often 
only for one week and this at the same time as the pressures 
are on medical staff to increase patient throughput. For you 
in your clinical studies it is even more important then, that 
you remember that you are in a process of adult learning, not 
passive teaching. There is the well known aphorism “see one, 
do one, teach one” 
But that had been anticipated by Confucius (you can see how I 
reckon the balance of political and economic power is going to 
develop) who said “I hear and I forget. I see and I remember. 
I do and I understand.”  
Keep looking; do not be happy with ticking the box; I have 
seen my case of whatever in this attachment. It is repetitive 
seeing that leads to remembering and if you get the chance 
then do and doing includes proper examination. Corrigan, of 
his pulse, the 19th century Dublin physician, said “The trouble 
with doctors is not that they don’t know enough, but that they 
don’t see enough”. Changes in junior doctors training due to 
European Working Time Directive and in the programmes 
themselves, have the trainees themselves complaining about 
lack of exposure. © The Ulster Medical Society, 2009.
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So how do these parts, education and management, look in the 
picture that is medical care? It was earlier this year sitting in a 
dive boat looking across a bay at all the yachts at anchor that 
I saw the answer. I was conscious of two styles of design. The 
first was an older design, of flowing lines, above and below 
water. It was well finished; there were cabins for the crew. The 
sail area was such that most of the time even when racing it 
was only at 95% of its performance and safety limits, so it 
did have a slight degree of slack to meet an emergency, that 
inevitably happens at sea. The other style is that of the modern 
extreme racing machine. It is absolutely stripped out, bunks 
for only half the crew, on a Cox and Box principle, no doors 
for privacy and the crew living in their oilskins. Underwater 
the keel and rudder are hung from narrow supports. It is 
driven at 100% or slightly over the safety margins of the 
rigging and sails, and with a minimal number of crew. The 
problem is there is no reserve and when parts break, or there is 
an injury, then at great expense parts or a temporary crewman 
is helicoptered in, things put right, and helicoptered out but 
only to leave the boat in the pre-existing state. 
So how is education and management being painted in? Over 
the years the sections have been frequently overpainted. At 
present it looks like the extreme model. I am reminded of the 
law propounded by Patrick Hutber, city editor of the Sunday 
Telegraph which states “improvement means deterioration”.   
So  for  all  involved  in  health  care,  and  not  just  those  in 
the medical profession, for everyone who works in or has 
influence in an institution such as this and that includes the 
porters, the administrators and even the politicians, as well 
as the doctors, nurses and allied professions there should be 
the same end picture.
We are all aware of how we react to our surroundings, our 
environment, our treatment on holiday, the lift we get or 
depression. If that is how we feel when well how much more 
important it is when ill.  But whatever is present in the outer 
parts of the picture, and making up the background, in the 
centre is a patient and not just a client. Isn’t it interesting 
how these less personal terms seem to slip in? But who is that 
patient? Is he a case or a real person? He has experiences, he 
has worries. So who is that patient? We were always taught to 
practice with the same care as you would wish if that patient 
was your parent, your sibling, your child, not just a bed, not 
just the twentieth psoriasis of the afternoon. 
There  are  those  here,  who  are  under  intense  pressure 
to  produce  good-looking  figures,  for  waiting  lists,  for 
throughputs, whatever their constituency, but to you can I 
also ask that you too consider the service provided. It is to 
an individual, a member of your family, your partner, your 
child, your parent. I pray that there is not a need to remember 
John Donne11 who said “I observe the physician with the same 
diligence as the disease.” He obviously in the 17th century 
had a different agenda, but we do have patients asking if 
decisions are finance or time based. To all who deliver care, 
and to all who plan, give time to the patients. That great 
philosopher Winnie the Pooh had the right approach when he 
said “Sometimes I sits and thinks and sometimes I just sits”. 
It is remarkable what solutions can be found, decisions made, 
and more importantly, ill considered decisions avoided. 
I started with Confucius, but let me finish with two others 
coming from different directions. The first is John Wesley, 
whose rule includes “do all the good you can, in all the ways 
you can, to all the people you can” and secondly one of the 
greatest thinkers of the last century Einstein. And though what 
he said was not to a medical audience it still applies: “The 
most beautiful thing we can experience is the mysterious. It 
is the source of all true art and all science”. (Note he says 
both all true art and all science. Not one or the other). And he 
continues “He to whom this emotion is a stranger, who can 
no longer pause to wonder and stand rapt in awe, is as good 
as dead: his eyes are closed”
Put those words of Wesley and Einstein together and it is not 
a bad way to practise medicine and the picture you paint will 
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